marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
INmune Bio Financial Ratios 2011-2024 | INMB
Annual Financial Ratios INmune Bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-7.0 | -6.1 | -5.4 | -19.5 | -6.4 | - | - | - | - | - | - | - | - |
P/S |
1363.1 | 443.4 | 899.2 | 21611.3 | - | - | - | - | - | - | - | - | - |
EPS |
-1.7 | -1.5 | -1.9 | -1.0 | -0.8 | -1.4 | -0.1 | - | - | - | - | - | - |
EV (Enterprise Value) |
194 M | 135 M | 108 M | 216 M | 43 M | 638 K | -1.06 M | 601 K | - | - | - | - | - |
EBITDA per Share |
-1.65 | -1.45 | -1.81 | -0.946 | -1.06 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-3.6 | -17.5 | -3.9 | - | - | - | - | - | - | - | - | ||
PEG |
- | -0.34 | 0.2 | - | - | - | - | - | - | - | - | ||
P/B |
5.5 | 2.8 | 2.0 | 6.1 | 2.1 | - | - | - | - | - | - | - | - |
P/CF |
-17.6 | -7.3 | -5.7 | -26.4 | -9.1 | - | - | - | - | - | - | - | - |
ROE % |
-80.36 | -45.42 | -37.82 | -31.22 | -32.52 | - | - | - | - | - | - | - | - |
ROA % |
-52.64 | -33.37 | -30.36 | -29.76 | -31.38 | - | - | - | - | - | - | - | - |
ROCE % |
-79.65 | -43.18 | -36.34 | -31.45 | -39.12 | - | - | - | - | - | - | - | - |
Current Ratio |
3.0 | 3.8 | 5.1 | 13.5 | 11.1 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | 60145.1 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios INmune Bio
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.6 | -0.5 | - | -0.48 | -0.36 | -0.36 | - | -0.43 | -0.38 | -0.39 | - | -0.55 | -0.44 | -0.32 | - | -0.36 | -0.2 | -0.19 | - | -0.28 | -0.04 | -0.2 | - | -0.18 | -0.71 | -0.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.61 | -0.51 | - | -0.47 | -0.36 | -0.36 | - | -0.41 | -0.36 | -0.36 | - | -0.52 | -0.44 | -0.32 | - | -0.37 | -0.2 | -0.19 | - | -0.29 | -0.04 | -0.2 | - | -0.18 | -0.71 | -0.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-97.11 | -78.68 | -44.15 | -56.27 | -48.91 | -45.85 | -31.03 | -41.75 | -40.34 | -45.95 | -33.28 | -45.45 | -46.90 | -36.95 | -22.95 | -35.94 | -36.76 | -32.98 | -22.70 | -32.01 | -28.33 | -64.00 | -63.85 | -63.85 | -54.54 | -17.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-68.81 | -55.22 | -31.82 | -41.04 | -36.60 | -34.59 | -23.85 | -32.63 | -24.88 | -35.85 | -26.66 | -38.27 | -41.08 | -35.31 | -21.88 | -34.41 | -35.34 | -31.76 | -21.90 | -30.77 | -27.11 | -61.06 | -60.82 | -60.82 | -51.95 | -16.39 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-97.78 | -78.67 | -43.68 | -55.37 | -47.64 | -44.12 | -29.38 | -39.60 | -38.14 | -44.17 | -32.54 | -44.97 | -47.19 | -37.47 | -23.27 | -36.34 | -36.96 | -33.34 | -22.97 | -32.28 | -28.53 | -64.04 | -63.85 | -63.85 | -54.54 | -17.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.7 | 3.4 | 3.0 | 3.5 | 3.7 | 4.0 | 3.8 | 4.2 | - | 5.0 | 5.1 | 5.5 | 3.5 | 28.5 | 21.4 | 21.4 | 21.4 | 21.4 | 28.4 | 28.4 | 28.4 | 28.4 | 21.1 | 21.1 | 21.1 | 21.1 | 59.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency